Drägerwerk AG & Co. KGaA/€DRW8
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA is a German company specializing in medical and safety technology. The company provides a range of products and solutions in the fields of critical care, which includes anesthesia workstations, ventilators, and patient monitoring, as well as safety products for personal protection, gas detection, and firefighting. Dräger was founded in 1889 and is headquartered in Lübeck, Germany. Its operations extend globally, serving various industries such as healthcare, emergency services, mining, and industrial applications. Drägerwerk's strategic strength lies in its focus on high-quality, technologically advanced products and its long-standing expertise in medical and safety technologies.
Ticker
€DRW8
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
16,615
ISIN
DE0005550602
Website
DRW8 Metrics
BasicAdvanced
€1.1B
-
-
0.38
€1.97
3.54%
Price and volume
Market cap
€1.1B
Beta
0.38
52-week high
€59.80
52-week low
€37.51
Average daily volume
1.5K
Dividend rate
€1.97
Financial strength
Current ratio
1.815
Quick ratio
0.97
Long term debt to equity
15.717
Total debt to equity
23.232
Dividend payout ratio (TTM)
28.77%
Interest coverage (TTM)
8.22%
Profitability
EBITDA (TTM)
231.845
Gross margin (TTM)
44.97%
Net profit margin (TTM)
3.42%
Operating margin (TTM)
4.43%
Effective tax rate (TTM)
28.79%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
3.06%
Return on equity (TTM)
7.78%
Valuation
Dividend yield (TTM)
3.54%
Forward dividend yield
3.54%
Growth
Revenue change (TTM)
0.51%
3-year revenue growth (CAGR)
1.84%
10-year revenue growth (CAGR)
3.15%
3-year dividend per share growth (CAGR)
120.25%
10-year dividend per share growth (CAGR)
3.86%
Bulls say / Bears say
Drägerwerk AG & Co. KGaA reported a significant increase in net sales for fiscal year 2023, growing by approximately 13% to €3,373.5 million, indicating strong market demand and operational efficiency. (finanzwire.com)
The company improved its earnings before interest and taxes (EBIT) to around €166 million in 2023, a substantial rise from the previous year's negative results, showcasing effective cost management and profitability enhancement. (finanzwire.com)
Drägerwerk increased its dividend for 2023 to €1.74 per common share and €1.80 per preferred share, reflecting confidence in its financial health and commitment to shareholder returns. (finanzwire.com)
In the first quarter of 2025, Drägerwerk's EBIT plummeted from €15.1 million in the previous year to €0.4 million, attributed to lower sales volumes and higher costs, raising concerns about short-term profitability. (marketscreener.com)
The medical division experienced a decline in net sales by 2.6% (net of currency effects) to around €1,900 million in 2024, primarily due to challenging market conditions in China, indicating potential regional vulnerabilities. (marketscreener.com)
Despite a positive outlook, Drägerwerk's forecast for 2024 anticipates a modest net sales increase of 1.0 to 5.0% and an EBIT margin of 2.5 to 5.5%, suggesting limited growth potential in the near term. (finanzwire.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Drägerwerk AG & Co. KGaA stock?
Drägerwerk AG & Co. KGaA (DRW8) has a market cap of €1.1B as of July 04, 2025.
What is the P/E ratio for Drägerwerk AG & Co. KGaA stock?
The price to earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DRW8) stock is 0 as of July 04, 2025.
Does Drägerwerk AG & Co. KGaA stock pay dividends?
Yes, the Drägerwerk AG & Co. KGaA (DRW8) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is €1.97 and the yield is 3.54%. Drägerwerk AG & Co. KGaA has a payout ratio of 28.77% on a trailing twelve-month basis.
When is the next Drägerwerk AG & Co. KGaA dividend payment date?
The next Drägerwerk AG & Co. KGaA (DRW8) dividend payment date is unconfirmed.
What is the beta indicator for Drägerwerk AG & Co. KGaA?
Drägerwerk AG & Co. KGaA (DRW8) has a beta rating of 0.38. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.